Inventor · disambiguated record
Ian Fleming
Also filed as: FLEMING IAN · FLEMING IAN N · FLEMING IAN NEIL
5 granted patents·5 pending applications·23 citations·filing 2003–2017
75Inventor score
Top patents by PatentIndex Score
10 records- 0187US8975239B2Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaineCYCLACEL LTD·Filed 2013·Granted Mar 10, 2015·16 cites·15 claims
- 0284US8349792B2Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agentCYCLACEL LTD·Filed 2007·Granted Jan 8, 2013·3 cites·14 claims
- 0374US9173938B2Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disordersGREEN SIMON·Filed 2009·Granted Nov 3, 2015·1 cites·19 claims
- 0471US8530445B2Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaineGREEN SIMON RICHARD·Filed 2009·Granted Sep 10, 2013·3 cites·40 claims
- 0549US2005164976A1Combination of a cdk inhibitor and 5-fu for the tratment of cancerCYCLACEL LTD·Filed 2003·Application pending·0 cites
- 0647US2013196938A1Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agentCYCLACEL LTD·Filed 2012·Application pending·0 cites
- 0742US2009274773A1Antiproliferative combination comprising cyc-682 and a cytotoxic agentCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 0840US2009306098A1Combination of roscovitine and a hdca inhibitor to treat proliferative diseasesCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 0936US11305019B2Functionalized nucleic acid nanostructures for RNA deliveryGUILD BIOSCIENCES·Filed 2017·Granted Apr 19, 2022·0 cites·20 claims
- 1035US2006052344A1Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone)MONTANA JOHN G·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Fleming files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →